Trial · NCT00430248
Registered outcomes17
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
1 to 17 of 17
Download this page as JSON| List | Outcome | Time frame | Description |
|---|---|---|---|
| Primary | Percentage of Subjects Whose Serum Urate Level is <6.0 Milligrams Per Deciliter (mg/dL) at the Final Visit. | Last Visit on treatment (up to 6 months) | The percentage of subjects whose serum urate level was \<6.0 mg/dL at the Final Visit was summarized. The Final Visit was the last visit at which a serum urate value was collected. |
| Secondary | Percentage of Renal Impairment Subjects Whose Final Visit Serum Urate Level is <6.0 mg/dl | Last Visit on treatment (up to 6 months) | The percentage of subjects with mild-to-moderate renal impairment whose serum urate was \<6.0 mg/dL at the final visit was summarized. The final visit was the last visit at which a serum urate value was collected. |
| Secondary | Percentage of Subjects Whose Serum Urate Levels Are <6.0 mg/dL at Month 2 Visit. | Month 2 | Serum urate values were obtained at the Month 2 visit. The percentage of subjects whose serum urate was \<6.0 mg/dL at the Month 2 visit was summarized. |
| Secondary | Percentage of Subjects Whose Serum Urate Levels Are <6.0 mg/dL at Month 4 Visit. | Month 4 | Serum urate values were obtained at the Month 4 visit. The percentage of subjects whose serum urate was \<6.0 mg/dL at the Month 4 visit was summarized. |
| Secondary | Percentage of Subjects Whose Serum Urate Levels Are <6.0 mg/dL at Month 6 Visit. | Month 6 | Serum urate values were obtained at the Month 6 visit. The percentage of subjects whose serum urate was \<6.0 mg/dL at the Month 6 visit was summarized. |
| Secondary | Percentage of Subjects Whose Serum Urate Levels Are <5.0 mg/dL at Month 2 Visit. | Month 2 | Serum urate values were obtained at the Month 2 visit. The percentage of subjects whose serum urate was \<5.0 mg/dL at the Month 2 visit was summarized. |
| Secondary | Percentage of Subjects Whose Serum Urate Levels Are <5.0 mg/dL at Month 4 Visit. | Month 4 | Serum urate values were obtained at the Month 4 visit. The percentage of subjects whose serum urate was \<5.0 mg/dL at the Month 4 visit was summarized. |
| Secondary | Percentage of Subjects Whose Serum Urate Levels Are <5.0 mg/dL at Month 6 Visit. | Month 6 | Serum urate values were obtained at the Month 6 visit. The percentage of subjects whose serum urate was \<5.0 mg/dL at the Month 6 visit was summarized. |
| Secondary | Percentage of Subjects Whose Serum Urate Levels Are <5.0 mg/dL at Final Visit. | Last Visit on treatment (up to 6 months) | The percentage of subjects whose serum urate level was \<5.0 mg/dL at the Final Visit was summarized. The Final Visit was the last visit at which a serum urate values was collected. |
| Secondary | Percentage of Subjects Whose Serum Urate Levels Are <4.0 mg/dL at Month 2 Visit | Month 2 | Serum urate values were obtained at the Month 2 visit. The percentage of subjects whose serum urate was \<4.0 mg/dL at the Month 2 visit was summarized. |
| Secondary | Percentage of Subjects Whose Serum Urate Levels Are <4.0 mg/dL at Month 4 Visit | Month 4 | Serum urate values were obtained at the Month 4 visit. The percentage of subjects whose serum urate was \<4.0 mg/dL at the Month 4 visit was summarized. |
| Secondary | Percentage of Subjects Whose Serum Urate Levels Are <4.0 mg/dL at Month 6 Visit | Month 6 | Serum urate values were obtained at the Month 6 visit. The percentage of subjects whose serum urate was \<4.0 mg/dL at the Month 6 visit was summarized. |
| Secondary | Percentage of Subjects Whose Serum Urate Levels Are <4.0 mg/dL at Final Visit | Last Visit on treatment (up to 6 months) | The percentage of subjects whose serum urate level was \<4.0 mg/dL at the Final Visit was summarized. The Final Visit was the last visit at which a serum urate values was collected. |
| Secondary | Mean Percent Change From Baseline in Serum Urate Levels at Month 2 Visit. | Baseline and Month 2 | Serum urate values were obtained at the Month 2 visit. The percent change in serum urate from baseline to the Month 2 visit was summarized. |
| Secondary | Mean Percent Change From Baseline in Serum Urate Levels at Month 4 Visit | Baseline and Month 4 | Serum urate values were obtained at the Month 4 visit. The percent change in serum urate from baseline to the Month 4 visit was summarized. |
| Secondary | Mean Percent Change From Baseline in Serum Urate Levels at Month 6 Visit. | Baseline and Month 6 | Serum urate values were obtained at the Month 6 visit. The percent change in serum urate from baseline to the Month 6 visit was summarized. |
| Secondary | Mean Percent Change From Baseline in Serum Urate Levels at Final Visit. | Baseline and Last Visit on treatment (up to 6 months) | The percent change in serum urate from baseline to the Final visit was summarized. The final visit was the last visit at which a serum urate value was collected. |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT00430248/registered